Overview
ISO 8934-1:2026 focuses on biotechnology standards for cell viability analytical methods, detailing general requirements and key considerations. Developed by the International Organization for Standardization (ISO), this standard provides a foundational framework for selecting, establishing, and reporting cell viability analytical methods. It emphasizes general guidelines for method selection, establishing fit-for-purpose approaches, and setting up standard operating procedures (SOPs). In addition, the standard addresses managing variability throughout pre-analytical, analytical, and post-analytical phases. It is applicable to a wide range of cell types-including cells in suspension, adhered cells, and cells in complex matrices-but is primarily tailored for nucleated mammalian cells.
Key Topics
- General Requirements: Lays out essential criteria for cell viability methods, ensuring accuracy, consistency, and reliability in measurements.
- Selection of Analytical Methods: Provides guidelines for choosing and developing cell viability analytical methods that are appropriate for the intended application.
- Standard Operating Procedures: Details the requirements for establishing robust SOPs specific to cell viability analyses, covering documentation, execution, and review.
- Managing Variability: Offers strategies for identifying and reducing sources of variability at each stage, from pre-analytical sample preparation to final data interpretation.
- Viable State Attributes: Discusses measurable attributes indicative of cell viability, like membrane integrity, metabolic activity, and the capacity for replication.
- Reporting Practices: Establishes a unified framework for consistent and transparent reporting of cell viability results and associated metadata.
Applications
ISO 8934-1:2026 is broadly applicable across the biotechnology sector where precise cell viability measurement is critical. Major application areas include:
- Cell and Gene Therapy: Assessing potency, safety, and efficacy of therapeutic cell preparations.
- Pharmaceutical Manufacturing: Quality control and release testing for cell banks, biological products, and cell-based products.
- Basic and Applied Research: Routine and specialized measurements in drug discovery, toxicity testing, and cellular research.
- Complex Sample Matrices: Standardized measurement methods for cells in suspension, adherent conditions, or embedded in complex biological matrices.
- Regulatory Compliance: Assisting laboratories in meeting global biomanufacturing and clinical standards through traceable, validated methods.
Related Standards
When applying ISO 8934-1:2026, users are encouraged to refer to other sector-specific or method-specific standards for additional requirements or expanded context, such as:
- ISO 20391-1:2018: Biotechnology – Cell counting – Part 1: General guidance on cell counting methods
- ISO 23033:2021: Biotechnology – Analytical methods for bioprocessing – General requirements
- ISO 9000:2015: Quality management systems – Fundamentals and vocabulary
- ISO 21899:2020: Biotechnology – General requirements for biobanking
These standards offer complementary guidance on definitions, method validation, calibration, qualification, and broader measurement frameworks within biotechnology and bioprocessing.
Practical Value
By implementing ISO 8934-1:2026, organizations ensure more reliable, reproducible, and interpretable cell viability measurements. This fosters consistent quality across research, product development, and manufacturing, supporting regulatory approval and market acceptance. The standard’s unified approach enables collaboration and comparison of results across institutions, supports innovation in analytical method development, and enhances the credibility of reported cell viability data.
Keywords: ISO 8934-1:2026, biotechnology standards, cell viability, analytical methods, method qualification, SOP, measurement variability, viable state attributes, cell-based products, biotechnology quality assurance.